Tag: GCP compliance

Transitioning Legacy Studies Into New TMF Platforms Safely

Posted on By digi

Transitioning Legacy Studies Into New TMF Platforms Safely Transitioning Legacy Studies Into New TMF Platforms Safely As the landscape of clinical research evolves, organizations must adapt by transitioning legacy studies into modern technology solutions. This tutorial provides a comprehensive, step-by-step guide for clinical operations, regulatory affairs, and medical affairs professionals on how to securely manage…

Read More “Transitioning Legacy Studies Into New TMF Platforms Safely” »

Essential Documents & TMF under GCP

Common Pitfalls in Clinical Risk Assessment and How to Avoid Them

Posted on By digi

Common Pitfalls in Clinical Risk Assessment and How to Avoid Them Common Pitfalls in Clinical Risk Assessment and How to Avoid Them Clinical trials represent a critical component of the drug development process, providing essential data on safety and efficacy. However, clinical risk assessment is equally important, involving the identification, evaluation, and mitigation of risks…

Read More “Common Pitfalls in Clinical Risk Assessment and How to Avoid Them” »

Risk Assessment & Risk Controls

Leveraging IRT Systems for Accountability and Temperature Control

Posted on By digi

Leveraging IRT Systems for Accountability and Temperature Control Leveraging IRT Systems for Accountability and Temperature Control In the realm of clinical trials, effective management of investigational products (IP) is imperative for both regulatory compliance and participant safety. This tutorial will systematically explore how Interactive Response Technology (IRT) systems can enhance accountability and temperature control of…

Read More “Leveraging IRT Systems for Accountability and Temperature Control” »

IP/Device Accountability & Temperature Excursions

Case Studies: IP and Excursion Issues That Triggered Inspection Findings

Posted on By digi

Case Studies: IP and Excursion Issues That Triggered Inspection Findings Case Studies: IP and Excursion Issues That Triggered Inspection Findings This tutorial provides a comprehensive analysis of investigational product (IP) accountability and excursion issues that could trigger regulatory inspection findings in oncology clinical research. It serves as a step-by-step guide for clinical operations, regulatory affairs,…

Read More “Case Studies: IP and Excursion Issues That Triggered Inspection Findings” »

IP/Device Accountability & Temperature Excursions

Partner and Vendor Documentation Responsibilities in the TMF

Posted on By digi

Partner and Vendor Documentation Responsibilities in the TMF Partner and Vendor Documentation Responsibilities in the TMF The conduct of clinical trials necessitates a well-defined framework for managing documentation to ensure compliance with Good Clinical Practice (GCP) guidelines. This article provides a comprehensive, step-by-step tutorial on the responsibilities regarding partner and vendor documentation within the Trial…

Read More “Partner and Vendor Documentation Responsibilities in the TMF” »

Essential Documents & TMF under GCP

Managing Paper, Hybrid and Fully Electronic TMF Models

Posted on By digi

Managing Paper, Hybrid and Fully Electronic TMF Models The trial master file (TMF) is a critical aspect of clinical research and is essential for demonstrating compliance with regulatory requirements throughout the lifecycle of a clinical trial. Maintaining an accurate and complete TMF is essential for compliance with Good Clinical Practice (GCP) and relevant regulations enforced…

Read More “Managing Paper, Hybrid and Fully Electronic TMF Models” »

Essential Documents & TMF under GCP

Case Studies: Risk Assessments That Prevented Major Quality Issues

Posted on By digi

Case Studies: Risk Assessments That Prevented Major Quality Issues In the highly regulated domain of clinical trials, risk assessment plays a critical role in ensuring compliance and maintaining the integrity of data collected. Methodologies and frameworks established by regulatory bodies such as the FDA, EMA, and MHRA, along with ICH guidelines, underscore the importance of…

Read More “Case Studies: Risk Assessments That Prevented Major Quality Issues” »

Risk Assessment & Risk Controls

Standard Operating Procedures for IP Management Across Sites and Studies

Posted on By digi

Standard Operating Procedures for IP Management Across Sites and Studies Standard Operating Procedures for IP Management Across Sites and Studies In the complex world of applied clinical trials, effective management of Investigational Products (IP) is critical for ensuring patient safety, data integrity, and regulatory compliance. The adoption of standardized operating procedures (SOPs) for IP management…

Read More “Standard Operating Procedures for IP Management Across Sites and Studies” »

IP/Device Accountability & Temperature Excursions

Training Pharmacists, Nurses and Coordinators on IP and Device Handling

Posted on By digi

Training Pharmacists, Nurses and Coordinators on IP and Device Handling Training Pharmacists, Nurses and Coordinators on IP and Device Handling In the context of clinical trials, the correct management of Investigational Products (IP) and medical devices is critical for ensuring patient safety, data integrity, and regulatory compliance. This comprehensive guide aims to instruct pharmacists, nurses,…

Read More “Training Pharmacists, Nurses and Coordinators on IP and Device Handling” »

IP/Device Accountability & Temperature Excursions

Archiving Periods, Formats and Access for TMF Under GCP

Posted on By digi

Archiving Periods, Formats and Access for TMF Under GCP Archiving Periods, Formats and Access for TMF Under GCP The management of Trial Master Files (TMF) is a critical aspect of clinical trial operations, particularly under the Good Clinical Practice (GCP) guidelines. This tutorial will provide detailed insights into archiving periods, formats, and access for TMFs,…

Read More “Archiving Periods, Formats and Access for TMF Under GCP” »

Essential Documents & TMF under GCP